Delivery Order SPE2DR25D7063-SPE2DR26F3CVS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,998.81 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on January 28, 2026, with completion scheduled for January 29, 2026. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a delivery order valued at $3,056.93 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 milliliter vials on January 18, 2026, with completion targeted for January 20, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used in cardiac care, reflecting the broad...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Procainamide 1 gram/10 milliliter vials totaling $9,116.21 with an ultimate completion date of January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award was fulfilled by AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, where the product will be...
- The Defense Logistics Agency awarded a delivery order valued at $4,532.88 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials on November 26, 2025, with an ultimate completion date of November 28, 2025. This competitive, non-set-aside contract utilizes firm fixed-price pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $5,796.65 to AmerisourceBergen Drug Corp for the supply of Procainamide 1,000 mg/10 mL vials on November 14, 2025, with completion expected by November 17, 2025. Procainamide is an antiarrhythmic medication used to treat cardiac arrhythmias, and this competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the vendor's Conshohocken, Pennsylvania location. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $1,652.29. The contract, awarded on December 23, 2025, with an ultimate completion date of December 24, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $5,005.35. This is a firm fixed-price delivery order with no set-aside designation, executed through competitive procurement. The product will be performed and delivered from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Procainamide 1 gram/10 mL vials with a ceiling value of $10,566.94. This firm fixed-price delivery order, with an ultimate completion date of August 21, 2025, represents a continuation of AmerisourceBergen's extensive federal pharmaceutical supply relationship. The contract was competitively awarded with no set-aside designation, consistent with the...
- The Defense Logistics Agency awarded a delivery order valued at $2,359.71 to AmerisourceBergen Drug Corp for the supply of Procainamide 1 Gram/10 mL vials (10 mL quantity). This firm fixed-price delivery order, issued on January 16, 2026, carries an ultimate completion date of January 20, 2026, and was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a $2,251.23 delivery order to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., on January 9, 2026, for the supply of Procainamide 1 gram/10 milliliter vials. This firm fixed-price delivery order is scheduled for completion by January 12, 2026, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition...
- SPE2DR25D7063Indefinite Delivery Contract
- SPE2DR25D7063-SPE2DR26F3CVSDelivery Order
The Defense Logistics Agency awarded a $1,513.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Procainamide 1 gram per 10 milliliter vials on January 28, 2026, with an ultimate completion date of January 29, 2026. This non-set-aside contract was competitively awarded and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Procainamide is an antiarrhythmic medication used to treat abnormal heart rhythms and is a critical pharmaceutical commodity for military medical treatment facilities and veteran healthcare programs. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s existing Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of an extensive range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The contract demonstrates Cencora's significant role as a primary pharmaceutical distributor for federal medical procurement, particularly serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 1/27/26 |